Paper · 42904883

The First 40 Years of Molecular Ophthalmology Part One: Inherited Retinal Disease: The 2026 Friedenwald Lecture.

Stone EM. Invest Ophthalmol Vis Sci, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. The First 40 Years of Molecular Ophthalmology Part One: Inherited Retinal Disease: The 2026 Friedenwald Lecture. Papers, record 42904883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42904883

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: The First 40 Years of Molecular Ophthalmology Part One: Inherited Retinal Disease: The 2026 Friedenwald Lecture.
Journal: Invest Ophthalmol Vis Sci
Year: 2026
Publication types: Journal Article
PubMed: https://pubmed.ncbi.nlm.nih.gov/42904883/
DOI: https://doi.org/10.1167/iovs.67.12.43
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13712374/
The journal: https://conductscience.org/library/journal-index/7703701
Revised in PubMed: 2026-11-02

Source PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Stone EM	Edwin M

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
R01 EY024605	NEI NIH HHS	United States	R01EY024605	PubMed	NIH RePORTER
R01 EY033331	NEI NIH HHS	United States	R01EY033331	PubMed	NIH RePORTER
R01 EY037073	NEI NIH HHS	United States	R01EY037073	PubMed	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	40,504,625	Device-free isolation of photoreceptor cells from patient iPSC-derived retinal organoids.	JCI Insight	2025	https://conductscience.org/library/papers/40504625	PubMed
2	21,559,507	Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice.	PLoS One	2011	https://conductscience.org/library/papers/21559507	PubMed
3	3,472,723	Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction.	Cold Spring Harb Symp Quant Biol	1986	https://conductscience.org/library/papers/3472723	PubMed
4	4,316,301	RNA-dependent DNA polymerase in virions of Rous sarcoma virus.	Nature	1970	https://conductscience.org/library/papers/4316301	PubMed
5	42,298,102	Efficient prime editing in vivo and in vitro using lipid nanoparticles.	Nat Nanotechnol	2026	https://conductscience.org/library/papers/42298102	PubMed
6	9,012,420	Improved set of short-tandem-repeat polymorphisms for screening the human genome.	Am J Hum Genet	1997	https://conductscience.org/library/papers/9012420	PubMed
7	4,316,300	RNA-dependent DNA polymerase in virions of RNA tumour viruses.	Nature	1970	https://conductscience.org/library/papers/4316300	PubMed
8	2,215,617	Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.	N Engl J Med	1990	https://conductscience.org/library/papers/2215617	PubMed
9	28,351,682	Two-photon polymerization for production of human iPSC-derived retinal cell grafts.	Acta Biomater	2017	https://conductscience.org/library/papers/28351682	PubMed
10	28,712,537	Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.	Lancet	2017	https://conductscience.org/library/papers/28712537	PubMed

1 to 10 of 22

See all 22 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42904883

GET https://conductscience.org/api/papers/v1/42904883/references?page=2

API reference For AI assistants